$130.52
+0.0400 (+0.0307%)
At Close: Jun 03, 2026
Masimo to Present in UBS Virtual Global Healthcare Conference
12:00am, Monday, 11'th May 2020
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present in the UBS Virtual Global Healthcare Conference on Monday, May 18, 2
ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q1 2020 Results - Earnings Call Transcript
07:18pm, Sunday, 10'th May 2020
ICU Medical, Inc. (NASDAQ:ICUI) Q1 2020 Earnings Conference Call May 7, 2020 16:30 ET Company Participants John Mills - Investor Relations, ICR Vivek Jain - Cha
'This disease is deadly': Doctor's stark message to 'growing complacency'
01:24pm, Sunday, 10'th May 2020
A Teesside doctor has shared his reservations about the Government relaxing the coronavirus regulations in his latest update
ICU Medical Inc (ICUI) Q1 2020 Earnings Call Transcript
06:30pm, Friday, 08'th May 2020
Thank you for joining us today to discuss the ICU Medical financial results for the first quarter of 2020. On the call today representing ICU Medical is Vivek Jain, Chief Executive Officer and Chairm
UPDATE: ICU Medical Says Has Not Received Reports Of Adverse Events Related To Recall
04:22pm, Friday, 08'th May 2020ICU Medical Issues Voluntary Nationwide Recall Of Lactated Ringer's Injection, Cites Presence Of Particulate Matter
04:22pm, Friday, 08'th May 2020
ICU Medical, Inc. is voluntarily recalling one single lot of Lactated Ringer's Injection, USP. The products are being recalled to the hospital/user level due to the presence of particulate matter iden
Raymond James Maintains Outperform on ICU Medical, Raises Price Target to $228
12:49pm, Friday, 08'th May 2020ICU Receives Shot in Arm in Q1 From COVID-19 Demand, but Uncertainty Leads to Lowered Guidance
08:46am, Friday, 08'th May 2020Edited Transcript of ICUI earnings conference call or presentation 7-May-20 8:30pm GMT
05:13am, Friday, 08'th May 2020
Q1 2020 ICU Medical Inc Earnings Call
ICU Cuts FY20 Adj. EBITDA Guidance From $240M-$260M To $230M-$250M, Adj. EPS From $6.50-$7.20 To $5.95-$6.65
08:52pm, Thursday, 07'th May 2020ICU Medical Q1 EPS $1.810 Beats $1.630 Estimate, Sales $328.600M Beat $296.300M Estimate
08:52pm, Thursday, 07'th May 2020ICU Medical, Inc. Announces First Quarter 2020 Results and Updates Fiscal Year 2020 Guidance
08:05pm, Thursday, 07'th May 2020
SAN CLEMENTE, Calif., May 07, 2020 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy.
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Sign In
Buy ICUI